| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |